NO20063917L - Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid - Google Patents
Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamidInfo
- Publication number
- NO20063917L NO20063917L NO20063917A NO20063917A NO20063917L NO 20063917 L NO20063917 L NO 20063917L NO 20063917 A NO20063917 A NO 20063917A NO 20063917 A NO20063917 A NO 20063917A NO 20063917 L NO20063917 L NO 20063917L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- phenyl
- ethyl
- acetamide
- synthesis
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 4
- 238000003786 synthesis reaction Methods 0.000 title abstract 4
- YMJLEPMVGQBLHL-UHFFFAOYSA-N 1h-pyrazole-5-carbonitrile Chemical compound N#CC1=CC=NN1 YMJLEPMVGQBLHL-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000012535 impurity Substances 0.000 abstract 3
- FZSDJRKAWHMQFF-UHFFFAOYSA-N n-[3-[3-(dimethylamino)prop-2-enoyl]phenyl]-n-ethylacetamide;hydrochloride Chemical compound Cl.CCN(C(C)=O)C1=CC=CC(C(=O)C=CN(C)C)=C1 FZSDJRKAWHMQFF-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- FFNKBQRKZRMYCL-UHFFFAOYSA-N 5-amino-1h-pyrazole-4-carbonitrile Chemical compound NC1=NNC=C1C#N FFNKBQRKZRMYCL-UHFFFAOYSA-N 0.000 abstract 1
- -1 pyrimidine-1-yl Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400325A HUP0400325A3 (en) | 2004-02-02 | 2004-02-02 | Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates |
| PCT/HU2005/000008 WO2005073235A2 (en) | 2004-02-02 | 2005-01-31 | Process for the synthesis of n- [3-(3-cyanopyrazolo [1,5a] pyrimidin-7-yl)-phenyl]-n-ethyl-acetamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063917L true NO20063917L (no) | 2006-11-01 |
Family
ID=89981959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063917A NO20063917L (no) | 2004-02-02 | 2006-09-01 | Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1711501B1 (de) |
| JP (1) | JP2007519700A (de) |
| AT (2) | ATE438647T1 (de) |
| DE (2) | DE602005015902D1 (de) |
| EA (1) | EA010830B1 (de) |
| HU (1) | HUP0400325A3 (de) |
| NO (1) | NO20063917L (de) |
| RS (1) | RS20060427A (de) |
| WO (1) | WO2005073235A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005099712A2 (en) * | 2004-04-19 | 2005-10-27 | Sanmar Speciality Chemicals Limited | Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide |
| WO2006070244A2 (en) * | 2004-11-22 | 2006-07-06 | Bakulesh Mafatlal Khamar | A process for the preparation of zaleplon |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4626538A (en) | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
| US5714607A (en) * | 1995-12-01 | 1998-02-03 | American Cyanamid Company | Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
| CA2450384A1 (en) | 2001-06-12 | 2002-12-19 | Biogal Gyogyszergyar Rt. | Process for the production of zaleplon |
| CZ200471A3 (cs) * | 2001-08-01 | 2004-11-10 | Biogal Gyogyszergyar Rt | Způsob purifikace N-[3-(3-kyanopyrazol[1,5-a]pyrimidin-7-yl)fenyl]-N-ethylacetamidu (zaleplon) a krystalické formy zaleplonu připravitelné tímto způsobem |
| PL207322B1 (pl) * | 2002-05-14 | 2010-11-30 | Adamed Społka Z Ograniczoną Odpowiedzialnością | Sposób wytwarzania zaleplonu |
-
2004
- 2004-02-02 HU HU0400325A patent/HUP0400325A3/hu unknown
-
2005
- 2005-01-31 EP EP05708499A patent/EP1711501B1/de active Active
- 2005-01-31 WO PCT/HU2005/000008 patent/WO2005073235A2/en active Application Filing
- 2005-01-31 DE DE602005015902T patent/DE602005015902D1/de not_active Expired - Fee Related
- 2005-01-31 JP JP2006550312A patent/JP2007519700A/ja active Pending
- 2005-01-31 EP EP08008434A patent/EP1950213B1/de active Active
- 2005-01-31 RS RSP-2006/0427A patent/RS20060427A/sr unknown
- 2005-01-31 EA EA200601417A patent/EA010830B1/ru not_active IP Right Cessation
- 2005-01-31 AT AT08008434T patent/ATE438647T1/de not_active IP Right Cessation
- 2005-01-31 DE DE602005012365T patent/DE602005012365D1/de not_active Expired - Fee Related
- 2005-01-31 AT AT05708499T patent/ATE420882T1/de not_active IP Right Cessation
-
2006
- 2006-09-01 NO NO20063917A patent/NO20063917L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1950213B1 (de) | 2009-08-05 |
| ATE438647T1 (de) | 2009-08-15 |
| ATE420882T1 (de) | 2009-01-15 |
| EA200601417A1 (ru) | 2006-12-29 |
| HUP0400325A3 (en) | 2005-11-28 |
| EP1950213A2 (de) | 2008-07-30 |
| DE602005012365D1 (de) | 2009-03-05 |
| JP2007519700A (ja) | 2007-07-19 |
| DE602005015902D1 (de) | 2009-09-17 |
| WO2005073235A2 (en) | 2005-08-11 |
| EA010830B1 (ru) | 2008-12-30 |
| EP1711501B1 (de) | 2009-01-14 |
| HU0400325D0 (en) | 2004-04-28 |
| WO2005073235A3 (en) | 2005-10-06 |
| EP1950213A3 (de) | 2008-08-13 |
| RS20060427A (en) | 2008-08-07 |
| HUP0400325A2 (hu) | 2005-09-28 |
| EP1711501A2 (de) | 2006-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8168784B2 (en) | Processes to make apoptosis promoters | |
| JP4319245B2 (ja) | ヒスタミン−３受容体拮抗薬 | |
| US5756817A (en) | O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same | |
| EP1527048B1 (de) | N-[phenyl(piperidin-2-yl)methyl]benzamid-derivate, verfahren zu deren herstellung und ihre therapeutische verwendung | |
| ES2199433T5 (es) | 3,3-diarilpropilaminas, su uso y preparacion. | |
| AU2004247487B2 (en) | N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline re-uptake inhibitors | |
| US20130158265A1 (en) | Sitagliptin, salts and polymorphs thereof | |
| OA11572A (en) | PyrroloÄ2,3-düpyrimidine compounds. | |
| WO1998015526A1 (en) | O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same | |
| NO20063917L (no) | Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid | |
| JPS58172379A (ja) | 新規なキナゾリン誘導体 | |
| KR102611847B1 (ko) | 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도 | |
| CA2189964A1 (en) | Novel diaminomethylidene derivative | |
| JP6368043B2 (ja) | 三環式ラクタム化合物の製造法 | |
| CN113121417A (zh) | 一种新型哌啶衍生物及其药物用途 | |
| WO2009084031A2 (en) | An improved process for preparation of (2e)-2-cyano-3-(3,4- dihydroxy-5-nitrophenyl)n,n-diethyl-2-propenamide polymorphic form a | |
| EP1716129A1 (de) | Piperazinderivate mit aktivität als inhibitoren der serotonin- und noradrenalin-wiederaufnahme | |
| KR100998067B1 (ko) | 비스(1-[(4-클로로페닐)페닐메틸]피페라진)-2,3-디벤조일 타르타르산 신규 중간체 염 및 이를 이용한 광학 활성적으로 순수한 1-[(4-클로로페닐)페닐메틸]피페라진을 분리하는 분리방법 | |
| CA3232921A1 (en) | Oximes and their use in treatment of gba-related diseases | |
| WO2010092286A1 (fr) | Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique | |
| NO843307L (no) | Cykloheksankarbonksylsyrer og derivater derav | |
| JP2007197397A (ja) | 多置換エチレンジアミン誘導体の製造方法 | |
| CA2751866A1 (fr) | Derives de n-[(6-aza-bicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique | |
| KR20060125987A (ko) | 감마-아미노레불리닉 엑시드 염산염 유도체 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |